FDA Inspection
Davion IncDavion Inc – FDA Inspection, Jan 24, 2025
Record Details
This FDA Inspection record concerns Davion Inc, with an inspection on January 24, 2025, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 48a2f912-5286-4d1c-8698-ea78ffbd00a0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1258459
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Davion Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 15, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 10, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 19, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Davion Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.